首页> 外文期刊>The journal of asthma >Validity and reliability evidence of the Asthma Control Test--ACT in Greece.
【24h】

Validity and reliability evidence of the Asthma Control Test--ACT in Greece.

机译:希腊哮喘控制测试-ACT的有效性和可靠性证据。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The dimensionality of the Asthma Control Test (ACT) was examined in two counterview studies. Up to now, the ACT has not been validated for the Greek asthma patients. OBJECTIVE: The present study was designed to examine the validity and reliability of the ACT responses in Greek asthma outpatients under a specialist's care. STUDY DESIGN: Following evidence for sample-specific validity, the ACT (n = 100) was examined through construct, cross-sectional, convergent, and discriminant validity as well as internal consistency and test-retest reliability [root mean squared error of approximation (RMSEA)]. RESULTS: A one-factor solution fit the data [chi(2) (chi-square) = 3.899, df (degrees of freedom) 5, ns, RMSEA <0.001]. The ACT showed a high internal consistency (Cronbach alpha = 0.72) and a high 2 months test-retest reliability (IR = 0.85) for the total sample. Significant differences were found between the five categories of asthma control patients (not controlled at all, poorly controlled, somewhat controlled, well controlled, and completely controlled), according to the specialists' rating, for the ACT (p < .001). Significant differences were found between patients with and without asthma control (p = .001), patients of different gender (p = .05), educational status (p = .05), mean year income (p = .01), body mass index (p = .05), follow-up visits (p = .01), as well as among patients of different age (p < .001) and severity (p < .001). An ACT score of 19 or less provided optimum balance of sensitivity (98.46) and specificity (88.57) for screening 'not controlled' asthma. Cross-sectional validity testing showed moderate correlation of the ACT score with FEV1% predicted (r = 0.57, p < .001) and disability (r = -0.42, p < .001) and moderately high correlation with dyspnea (r = -0.71, p < .001). Convergent validity testing showed that the ACT score was correlated with the specialists' rating (r = 0.89, p < .001). CONCLUSION: The ACT is valid and reliable in Greek outpatients with asthma under a specialist's care.
机译:背景:在两项对抗观察研究中检查了哮喘控制测试(ACT)的维度。迄今为止,ACT尚未针对希腊哮喘患者进行验证。目的:本研究旨在检查在专家护理下的希腊哮喘门诊患者ACT反应的有效性和可靠性。研究设计:根据样本特异性有效性的证据,通过结构,横截面,收敛性和判别有效性以及内部一致性和重测信度[近似均方根误差( RMSEA)]。结果:单因素解决方案拟合数据[chi(2)(卡方)= 3.899,df(自由度)5,ns,RMSEA <0.001)。 ACT显示出高的内部一致性(Cronbach alpha = 0.72)和2个月的高重测信度(IR = 0.85)。根据专家的评分,在ACT的五种哮喘控制患者之间发现了显着差异(完全不受控制,控制不力,有些控制,良好控制和完全控制)(p <.001)。在有和没有哮喘控制的患者(p = .001),不同性别的患者(p = .05),教育程度(p = .05),平均年收入(p = .01),体重之间发现了显着差异指数(p = .05),随访次数(p = .01)以及不同年龄(p <.001)和严重程度(p <.001)的患者之间。 ACT得分不超过19可以为筛查“非控制性”哮喘提供灵敏度(98.46)和特异性(88.57)的最佳平衡。横断面有效性测试显示ACT评分与FEV1%预测值(r = 0.57,p <.001)和残疾(r = -0.42,p <.001)有中等相关性,与呼吸困难(r = -0.71)有中等相关性,p <.001)。收敛性有效性测试表明,ACT评分与专家评分相关(r = 0.89,p <.001)。结论:ACT在希腊专科门诊哮喘患者中有效且可靠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号